ABK Biomedical: ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors

HALIFAX, NS, April 19, 2022 /PRNewswire/ - ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization ...